FDA responds to consumer demands on DEHP labelling
This article was originally published in Clinica
Executive Summary
Manufacturers of certain medical devices made of polyvinyl chloride may soon have to include a warning label or other information that the product contains the plasticiser, DEHP. The FDA disclosed that this was in prospect in a letter responding to a citizen petition filed by Health Care Without Harm (HCHW). The consumer group had requested that the FDA require that all devices containing the PVC softener carry a safety warning.